Mineralocorticoid Receptor Blockade Mitigates Loop Diuretic-Exacerbated Plasma Volume Contraction and Target-Organ Fibrosis in Angiotensin II-Induced Hypertension
International Journal of Molecular Sciences · 16.09.2026 · 27 (18) · 8251
DOI: 10.3390/ijms27188251 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.09.2026. Verfasst von Junxian Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology & Biomedical Sciences, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Repub…. Hauptthemen laut MEDLINE: Hypertension, Angiotensin II, Mineralocorticoid Receptor Antagonists, Plasma Volume. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean Society of Hypertension, National Natural Science Foundation of China.
Abstract (Originalsprache)
Diuretics are widely used antihypertensive agents because of their potent natriuretic effects. However, in hypertension with excessive renin–angiotensin–aldosterone system (RAAS) activation, further volume depletion may aggravate target-organ injury. We investigated the effects of loop diuretics and mineralocorticoid receptor (MR) blockade on plasma volume (PV) and organ injury in angiotensin II (Ang II)-induced hypertension. Male Sprague–Dawley rats were assigned to six groups (n = 6/group) receiving Sham or Ang II with or without furosemide and spironolactone. PV was measured by indocyanine green (ICG) dilution, together with blood pressure, histological, immunohistochemical, and molecular assessments. Longitudinal data were analyzed by two-way repeated-measures ANOVA; animal-level endpoints by one-way ANOVA; histological and immunohistochemical measurements by nested one-way ANOVA; and two-group comparisons by unpaired t tests, with appropriate post hoc testing. Ang II reduced PV, whereas furosemide caused a further decline without additional blood pressure reduction, accompanied by aggravated fibrosis, endothelial impairment, and dysregulation of fibrosis-related proteins. Spironolactone attenuated PV contraction, lowered blood pressure, preserved endothelial integrity, alleviated fibrosis, and partially normalized molecular alterations. MR blockade was associated with attenuation of PV contraction and target-organ injury, supporting a potential relationship between PV homeostasis and organ protection during chronic loop diuretic treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology & Biomedical Sciences, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
- Yanbian University Hospital, Yanbian University, Yanji 133000, China.
ORCID-Profile: Junxian Liu, Yin Hua Zhang
Förderung
- National Research Foundation of Korea
- Korean Society of Hypertension
- National Natural Science Foundation of China
Zitieren
APA
Liu, J., & Zhang, Y. H. (2026). Mineralocorticoid Receptor Blockade Mitigates Loop Diuretic-Exacerbated Plasma Volume Contraction and Target-Organ Fibrosis in Angiotensin II-Induced Hypertension. International Journal of Molecular Sciences, 27(18), 8251. https://doi.org/10.3390/ijms27188251
Vancouver
Liu J, Zhang YH. Mineralocorticoid Receptor Blockade Mitigates Loop Diuretic-Exacerbated Plasma Volume Contraction and Target-Organ Fibrosis in Angiotensin II-Induced Hypertension. International Journal of Molecular Sciences. 2026;27(18):8251. doi:10.3390/ijms27188251
BibTeX
@article{Liu2026,
author = {Liu, Junxian and Zhang, Yin Hua},
title = {Mineralocorticoid Receptor Blockade Mitigates Loop Diuretic-Exacerbated Plasma Volume Contraction and Target-Organ Fibrosis in Angiotensin II-Induced Hypertension},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {18},
pages = {8251},
doi = {10.3390/ijms27188251}
}
EUVIMED